 Nikoloz Shkriabai
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 9 | 2017 | 67 | 1.070 |
Why?
| | HIV-1 | 11 | 2022 | 768 | 0.970 |
Why?
| | HIV Integrase Inhibitors | 5 | 2016 | 62 | 0.750 |
Why?
| | Human T-lymphotropic virus 1 | 5 | 2023 | 23 | 0.710 |
Why?
| | Acetates | 2 | 2014 | 94 | 0.560 |
Why?
| | Virus Integration | 9 | 2022 | 68 | 0.560 |
Why?
| | Indoles | 1 | 2014 | 300 | 0.390 |
Why?
| | Protein Binding | 17 | 2021 | 1888 | 0.390 |
Why?
| | DNA, Viral | 5 | 2017 | 349 | 0.340 |
Why?
| | Drug Resistance, Viral | 3 | 2014 | 99 | 0.320 |
Why?
| | Anti-HIV Agents | 3 | 2022 | 663 | 0.310 |
Why?
| | Mutation, Missense | 3 | 2014 | 294 | 0.300 |
Why?
| | HEK293 Cells | 11 | 2020 | 589 | 0.290 |
Why?
| | Gene Products, tax | 2 | 2019 | 9 | 0.290 |
Why?
| | Cell Cycle Proteins | 5 | 2017 | 549 | 0.280 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2013 | 347 | 0.260 |
Why?
| | Virus Replication | 3 | 2021 | 395 | 0.260 |
Why?
| | Viral Nonstructural Proteins | 2 | 2016 | 54 | 0.260 |
Why?
| | RNA, Viral | 4 | 2017 | 565 | 0.250 |
Why?
| | DNA Damage | 3 | 2021 | 351 | 0.240 |
Why?
| | Integrases | 3 | 2017 | 116 | 0.240 |
Why?
| | Hepacivirus | 2 | 2016 | 228 | 0.240 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 62 | 0.230 |
Why?
| | Leukemia Virus, Murine | 2 | 2014 | 16 | 0.220 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 4 | 0.220 |
Why?
| | Capsid | 2 | 2021 | 74 | 0.220 |
Why?
| | Transcription Factors | 3 | 2017 | 1526 | 0.210 |
Why?
| | Protein Multimerization | 2 | 2014 | 157 | 0.200 |
Why?
| | Prions | 1 | 2022 | 33 | 0.200 |
Why?
| | Nucleosomes | 2 | 2014 | 122 | 0.190 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 40 | 0.180 |
Why?
| | Necrosis | 1 | 2021 | 209 | 0.170 |
Why?
| | Neuroblastoma | 1 | 2021 | 133 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 82 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 4 | 2019 | 129 | 0.170 |
Why?
| | HTLV-I Infections | 3 | 2019 | 21 | 0.160 |
Why?
| | Nuclear Proteins | 2 | 2014 | 591 | 0.160 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 295 | 0.160 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 43 | 0.160 |
Why?
| | Receptors, Virus | 1 | 2019 | 75 | 0.160 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1311 | 0.140 |
Why?
| | Allosteric Regulation | 2 | 2014 | 81 | 0.140 |
Why?
| | Avian Leukosis Virus | 1 | 2017 | 6 | 0.140 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 31 | 0.140 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 49 | 0.140 |
Why?
| | Mass Spectrometry | 7 | 2016 | 622 | 0.140 |
Why?
| | Cyclophilin A | 1 | 2016 | 24 | 0.130 |
Why?
| | Ribonuclease P | 1 | 2016 | 25 | 0.130 |
Why?
| | Virion | 1 | 2016 | 73 | 0.130 |
Why?
| | Nucleic Acids | 1 | 2016 | 58 | 0.130 |
Why?
| | Genome, Viral | 1 | 2016 | 118 | 0.130 |
Why?
| | Models, Molecular | 7 | 2017 | 1368 | 0.130 |
Why?
| | Catalytic Domain | 1 | 2016 | 196 | 0.120 |
Why?
| | Calcium | 1 | 2021 | 1089 | 0.120 |
Why?
| | RNA, Transfer | 1 | 2016 | 118 | 0.120 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 39 | 0.120 |
Why?
| | Hepatitis C | 1 | 2016 | 218 | 0.110 |
Why?
| | Quinolines | 1 | 2014 | 129 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 397 | 0.110 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 40 | 0.110 |
Why?
| | Cell Nucleus | 2 | 2021 | 552 | 0.100 |
Why?
| | Protein Domains | 3 | 2020 | 207 | 0.100 |
Why?
| | beta Karyopherins | 1 | 2012 | 6 | 0.100 |
Why?
| | Viral Proteins | 1 | 2014 | 281 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 399 | 0.100 |
Why?
| | Crystallography, X-Ray | 3 | 2020 | 402 | 0.100 |
Why?
| | Amino Acid Motifs | 3 | 2021 | 197 | 0.100 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 26 | 0.100 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 134 | 0.100 |
Why?
| | Amino Acid Sequence | 4 | 2019 | 1981 | 0.100 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2022 | 31 | 0.100 |
Why?
| | Humans | 23 | 2023 | 114080 | 0.090 |
Why?
| | HIV Reverse Transcriptase | 1 | 2011 | 29 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 12 | 0.090 |
Why?
| | Viral Core Proteins | 1 | 2011 | 20 | 0.090 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2011 | 82 | 0.090 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 51 | 0.090 |
Why?
| | Virology | 1 | 2010 | 19 | 0.090 |
Why?
| | Aptamers, Nucleotide | 1 | 2011 | 73 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 133 | 0.090 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 56 | 0.090 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1228 | 0.090 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 101 | 0.080 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 1 | 2009 | 5 | 0.080 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 796 | 0.080 |
Why?
| | Binding Sites | 3 | 2021 | 1166 | 0.080 |
Why?
| | DNA Footprinting | 1 | 2008 | 28 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 386 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 283 | 0.080 |
Why?
| | HIV Infections | 1 | 2022 | 2453 | 0.080 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 142 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 396 | 0.070 |
Why?
| | DNA Repair | 1 | 2009 | 184 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 385 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 363 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 109 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 563 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 960 | 0.060 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 15 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 89 | 0.050 |
Why?
| | Cell Line | 3 | 2014 | 2629 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 57 | 0.050 |
Why?
| | Drugs, Investigational | 1 | 2022 | 30 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2022 | 68 | 0.050 |
Why?
| | Phosphorylation | 2 | 2021 | 1559 | 0.050 |
Why?
| | Glycine | 1 | 2022 | 152 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 534 | 0.050 |
Why?
| | Nuclear Pore | 1 | 2021 | 14 | 0.050 |
Why?
| | Reverse Transcription | 1 | 2021 | 18 | 0.050 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 13 | 0.050 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 29 | 0.040 |
Why?
| | Protein Conformation | 2 | 2014 | 803 | 0.040 |
Why?
| | Cytoplasm | 1 | 2021 | 255 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 499 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 845 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 3 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 12 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 10 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1131 | 0.040 |
Why?
| | Chromatography, Gel | 2 | 2009 | 122 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 522 | 0.040 |
Why?
| | Histones | 2 | 2014 | 529 | 0.040 |
Why?
| | Virulence | 1 | 2019 | 228 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 300 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2783 | 0.040 |
Why?
| | Chick Embryo | 1 | 2017 | 122 | 0.030 |
Why?
| | Nucleoproteins | 1 | 2017 | 27 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1014 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1350 | 0.030 |
Why?
| | Nucleocapsid | 1 | 2016 | 17 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2017 | 218 | 0.030 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2016 | 80 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 135 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 133 | 0.030 |
Why?
| | Morphogenesis | 1 | 2016 | 159 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4501 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 350 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1068 | 0.030 |
Why?
| | Retroviridae Proteins | 1 | 2014 | 11 | 0.030 |
Why?
| | Histidine | 1 | 2014 | 57 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2014 | 95 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 771 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 137 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 410 | 0.030 |
Why?
| | Azepines | 1 | 2013 | 69 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 128 | 0.030 |
Why?
| | Base Sequence | 1 | 2016 | 2114 | 0.030 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 20 | 0.030 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 84 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 261 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 135 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2349 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 176 | 0.020 |
Why?
| | Triazoles | 1 | 2013 | 125 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1611 | 0.020 |
Why?
| | Animals | 4 | 2017 | 31570 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1757 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 636 | 0.020 |
Why?
| | Protein Footprinting | 1 | 2011 | 9 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 431 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 31 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 128 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 47 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 89 | 0.020 |
Why?
| | Retroviridae | 1 | 2010 | 89 | 0.020 |
Why?
| | Protein Subunits | 1 | 2011 | 200 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2013 | 437 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2010 | 200 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 167 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 140 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 754 | 0.020 |
Why?
| | Point Mutation | 1 | 2009 | 216 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 115 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 325 | 0.020 |
Why?
| | Proteomics | 1 | 2013 | 815 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2699 | 0.020 |
Why?
| | Proteins | 1 | 2010 | 906 | 0.010 |
Why?
| | Peptides | 1 | 2009 | 847 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3338 | 0.010 |
Why?
| | Mice | 1 | 2013 | 14847 | 0.010 |
Why?
|
|
Shkriabai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|